This issue brief provides a one-page overview of the epidemic and select AMA advocacy initiatives and resources.
American Medical Association
State Toolkit to End the Nation’s Drug Overdose Epidemic: Leading-Edge Actions and Strategies to Remove Barriers to Evidence-based Patient Care
The AMA and Manatt Health 2022 State Toolkit identifies more than 400 state laws, regulations, policy guidance and other select national actions being implemented to help end the nation’s drug overdose epidemic.
2022 MHPAEA Report to Congress – AMA Summary
“This report underscores two simple facts: insurers will not change their behaviors without increased enforcement and accountability, and patients will continue to suffer until that happens,” according to the letter from AMA CEO James L. Madara, M.D.
AMA model harm reduction bill
This AMA model bill is a 2021 update of longstanding AMA advocacy. Provisions include:
- Enhanced protections for Good Samaritans who seek help during an overdose event
- Broad support for needle exchange and syringe services programs
- Increased authority to distribute and increase access to naloxone
- Decriminalization of fentanyl test strips and other drug checking supplies
For more information, contact [email protected]
Recommendations of AMA Substance Use and Pain Care Task Force
Issued September 2021
AMA prescription drug monitoring program national survey
Physicians and other authorized users queried state prescription drug monitoring programs (PDMPs) more than 910,000,000 times in 2020; more than double compared to 2018.